Shkreli's KaloBios buys an old drug with eyes on a lucrative FDA...
FierceBiotech-21 hours ago
KaloBios plans to file for the FDA's fast-track designation in hopes of scoring a quick approval for benznidazole without
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
No comments:
Post a Comment